Unlocking the Potential of <i>Phyllanthus</i> Species From Traditional Knowledge to Clinical Trials: An Updated Review of Metabolomics Approach in Diabetes Intervention

Phyllanthus species have been known for their medicine and food homology properties in the management of diabetes and related metabolic disorders. This review provides the scientific insights supporting the potential in diabetes prevention and intervention. Descriptions of the geographical distribution and traditional usage highlight the similarities and differences among selected Phyllanthus species, that is, Phyllanthus niruri L., Phyllanthus urinaria L. and Phyllanthus acidus (L.) Skeels, known for their extensive conventional usage in Southeast Asia, particularly Malay Peninsula. Their rich phytochemical profiles, well-documented antidiabetic properties and abundant existing research necessitate a review for potential sustainable food and clinical applications. Metabolomics unlocked the therapeutic avenues of Phyllanthus species for a more sustainable and natural option for diabetes remedies. The overview of phytochemical fingerprints and bioactive compounds in Phyllanthus plants, and the elucidation of biomarker pathways deepened the understanding of antidiabetic properties of these medicinal plants. Additionally, the toxicological data revealed that lower dosages of Phyllanthus species are safe for consumption without significant adverse effects. Data from 2010 to 2025 for in vitro and in vivo antidiabetic studies demonstrated the capability of Phyllanthus species as anti-hyperglycemic agent. Nevertheless, limited clinical trials have shown prominent antidiabetic properties. Standardized polyherbal marketed products and patents incorporating Phyllanthus species in various formulations have been abundantly filed. Overall, this review offers a comprehensive insight into the role of bioactive phytoconstituents in Phyllanthus species and enhance the prospects in the advancement of functional food ingredients and drug discovery for diabetes management.

Authors

Institutions

Publication Details

Journal
Phytotherapy Research
Published
2026-01-15
DOI
https://doi.org/10.1002/ptr.70153
Primary Topic
Phytochemistry and Bioactivity Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unlocking the Potential of Phyllanthus Species From Traditional Knowledge to Clinical Trials: An Updated Review of Metabolomics Approach in Diabetes Intervention

Hamidun Bunawan, Habsah Aziz, Siti Norliyana Zubaidi, Pei Lou Wong et al.
Phytotherapy Research
Phytochemistry and Bioactivity Studies
article

Unlocking the Potential of Phyllanthus Species From Traditional Knowledge to Clinical Trials: An Updated Review of Metabolomics Approach in Diabetes Intervention

Hamidun Bunawan, Habsah Aziz, Siti Norliyana Zubaidi, Pei Lou Wong, Nurkhalida Kamal, Syarul Nataqain Baharum, Faridah Abas, Ahmed Mediani, Hesham Ali El Enshasy, Adilah Aiman Zafir Khan
article en

Abstract

Phyllanthus species have been known for their medicine and food homology properties in the management of diabetes and related metabolic disorders. This review provides the scientific insights supporting the potential in diabetes prevention and intervention. Descriptions of the geographical distribution and traditional usage highlight the similarities and differences among selected Phyllanthus species, that is, Phyllanthus niruri L., Phyllanthus urinaria L. and Phyllanthus acidus (L.) Skeels, known for their extensive conventional usage in Southeast Asia, particularly Malay Peninsula. Their rich phytochemical profiles, well-documented antidiabetic properties and abundant existing research necessitate a review for potential sustainable food and clinical applications. Metabolomics unlocked the therapeutic avenues of Phyllanthus species for a more sustainable and natural option for diabetes remedies. The overview of phytochemical fingerprints and bioactive compounds in Phyllanthus plants, and the elucidation of biomarker pathways deepened the understanding of antidiabetic properties of these medicinal plants. Additionally, the toxicological data revealed that lower dosages of Phyllanthus species are safe for consumption without significant adverse effects. Data from 2010 to 2025 for in vitro and in vivo antidiabetic studies demonstrated the capability of Phyllanthus species as anti-hyperglycemic agent. Nevertheless, limited clinical trials have shown prominent antidiabetic properties. Standardized polyherbal marketed products and patents incorporating Phyllanthus species in various formulations have been abundantly filed. Overall, this review offers a comprehensive insight into the role of bioactive phytoconstituents in Phyllanthus species and enhance the prospects in the advancement of functional food ingredients and drug discovery for diabetes management.

Phytotherapy ResearchVol. 40(3)
Universiti Putra Malaysia (MY), City of Scientific Research and Technological Applications (EG), University of Technology Malaysia (MY), National University of Malaysia (MY)
Universiti Kebangsaan Malaysia
Zero hunger
Openalex Percentile: Top 86%
Phytochemistry and Bioactivity Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.